Skip to main content

Published locations for Use of the JAK1/JAK2 inhibitor ruxolitinib in the treatment of patients with myelofibrosis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Use of the JAK1/JAK2 inhibitor ruxolitinib in the treatment of patients with myelofibrosis

User login

  • Reset your password
  • /content/use-jak1/jak2-inhibitor-ruxolitinib-treatment-patients-myelofibrosis-0
  • /jcso/article/130787/patient-survivor-care/use-jak1/jak2-inhibitor-ruxolitinib-treatment-patients
  • /hematology-oncology/article/130787/patient-survivor-care/use-jak1/jak2-inhibitor-ruxolitinib